Open AccessLong-term efficacy of CAR-T cell therapy for patients with relapsed/refractory B cell non-Hodgkin lymphoma
Author(s) -
Shan Fu,
Yongxian Hu,
He Huang
Publication year - 2022
Publication title -
zhejiang daxue xuebao. yixue ban
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.14
H-Index - 13
ISSN - 1008-9292
DOI - 10.3724/zdxbyxb-2022-0049
Subject(s) - medicine , lymphoma , refractory (planetary science) , survival rate , gastroenterology , chimeric antigen receptor , cytokine release syndrome , oncology , immunology , immunotherapy , cancer , biology , astrobiology
To evaluate the long-term efficacy of chimeric antigen receptor (CAR) T cell therapy in treatment of relapsed/refractory B cell non-Hodgkin lymphoma (B-NHL).